Some studies found that activated GSK-3β inhibits EMT, as indicated by the decreased levels of vimentin and α-SMA and increased levels of E-cadherin, thereby alleviating pulmonary fibrosis 51, 91. The gene discussed is ACTA1; the disease is pulmonary fibrosis.